COMPLETED

Self Biophysical Profile Using a Home Ultrasound Device Proof of Concept

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is to assess if patients presenting for antenatal testing can complete a Bio Physical Score (BPP) with a home-use ultrasound with remote clinician guidance.

Official Title

BPP for ME: Self Biophysical Profile Proof of Concept

Quick Facts

Study Start:2024-04-10
Study Completion:2024-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06442358

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18 years old
  2. * Singleton pregnancy
  3. * Gestational age ≥ 24 0/7 weeks
  4. * No known major fetal or genetic anomalies (may include: isolated pyelectasis, isolated --VSD, multicystic dysplastic kidney, cleft lip/palate, club foot, etc.)
  5. * Ability to understand and sign informed consent in English
  6. * Ability to read and understand instructions in English
  7. * Ability to hold an ultrasound probe and respond to clinician instructions
  8. * BMI less than 40 at initial prenatal visit
  9. * Scheduled biophysical profile (BPP)
  10. * Any maternal/pregnancy complications requiring antenatal testing, including but not limited to intrauterine growth restriction, chronic or gestational hypertension, preexisting or gestational diabetes, autoimmune disorder, etc.
  1. * Multiple gestation
  2. * Known major fetal structural anomaly or aneuploidy
  3. * Known fetal or genetic anomalies
  4. * Ruptured membranes
  5. * Uterine complaints, such as painful contractions
  6. * Maternal concern for decreased fetal movement
  7. * Not evaluated vaginal bleeding (not including spotting)
  8. * Fetal or maternal criteria that require urgent delivery
  9. * BMI ≥ 40 at initial prenatal visit

Contacts and Locations

Principal Investigator

Alex Peahl, MD
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

University of Michigan
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: PulseNmore

  • Alex Peahl, MD, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-10
Study Completion Date2024-12-30

Study Record Updates

Study Start Date2024-04-10
Study Completion Date2024-12-30

Terms related to this study

Additional Relevant MeSH Terms

  • Perinatal Care